A New Scoring Tool to Assess Overall Survival in Patients With Intracerebral Metastases From Gynecological Cancers

Dirk Rades, Stefan Janssen, Amira Bajrovic, Theo Veninga, Dorothea Fischer, Steven E. Schild

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: This study aimed to facilitate individualized treatment strategies for intracerebral metastases from gynecological cancers by creating a specific overall survival (OS) score. Methods/Materials Fifty-six patients irradiated for cerebral metastases from gynecological cancers were included. Eleven factors were retrospectively analyzed for OS: age, Eastern Cooperative Oncology Group (ECOG) performance score, cancer type, histology, histologic grading, initial stage, number of lesions, extracerebral metastases, time between cancer diagnosis and brain metastases treatment, recursive partitioning analysis class, and type of treatment. Independent predictors of OS were incorporated in the score (better OS, 1 point; worse OS, 0 points). Results: On Cox proportional hazards analysis, performance score (hazards ratio, 1.98; 95% confidence interval, 1.30-3.23; P = 0.001), no extracerebral metastases (3.34; 1.46-8.96; P = 0.003), and recursive partitioning analysis class 1 (3.27; 1.97-5.65; P < 0.001) were significant. The following points were assigned: ECOG score 1 to 2 = 1 point, ECOG score 3 to 4 = 0 points, no extracerebral metastases = 1 point, extracerebral metastases = 0 points. Sum scores were 0 (n = 32), 1 (n = 15), or 2 points (n = 9). Six-month OS rates were 6%, 67%, and 100%, respectively (P < 0.001). Conclusions: A predictive tool including 3 groups with significantly different OS probabilities was designed for patients with cerebral metastases from gynecological cancers. This tool will aid in choosing individual treatments.

Original languageEnglish (US)
Pages (from-to)597-602
Number of pages6
JournalInternational Journal of Gynecological Cancer
Volume27
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Neoplasm Metastasis
Survival
Neoplasms
Therapeutics
Brain Neoplasms
Histology
Survival Rate
Confidence Intervals

Keywords

  • Brain metastases
  • Gynecological cancers
  • Irradiation
  • Overall survival
  • Scoring tool

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

A New Scoring Tool to Assess Overall Survival in Patients With Intracerebral Metastases From Gynecological Cancers. / Rades, Dirk; Janssen, Stefan; Bajrovic, Amira; Veninga, Theo; Fischer, Dorothea; Schild, Steven E.

In: International Journal of Gynecological Cancer, Vol. 27, No. 3, 01.03.2017, p. 597-602.

Research output: Contribution to journalArticle

Rades, Dirk ; Janssen, Stefan ; Bajrovic, Amira ; Veninga, Theo ; Fischer, Dorothea ; Schild, Steven E. / A New Scoring Tool to Assess Overall Survival in Patients With Intracerebral Metastases From Gynecological Cancers. In: International Journal of Gynecological Cancer. 2017 ; Vol. 27, No. 3. pp. 597-602.
@article{993f748d0e9f40b5b51441b6f15a058b,
title = "A New Scoring Tool to Assess Overall Survival in Patients With Intracerebral Metastases From Gynecological Cancers",
abstract = "Objective: This study aimed to facilitate individualized treatment strategies for intracerebral metastases from gynecological cancers by creating a specific overall survival (OS) score. Methods/Materials Fifty-six patients irradiated for cerebral metastases from gynecological cancers were included. Eleven factors were retrospectively analyzed for OS: age, Eastern Cooperative Oncology Group (ECOG) performance score, cancer type, histology, histologic grading, initial stage, number of lesions, extracerebral metastases, time between cancer diagnosis and brain metastases treatment, recursive partitioning analysis class, and type of treatment. Independent predictors of OS were incorporated in the score (better OS, 1 point; worse OS, 0 points). Results: On Cox proportional hazards analysis, performance score (hazards ratio, 1.98; 95{\%} confidence interval, 1.30-3.23; P = 0.001), no extracerebral metastases (3.34; 1.46-8.96; P = 0.003), and recursive partitioning analysis class 1 (3.27; 1.97-5.65; P < 0.001) were significant. The following points were assigned: ECOG score 1 to 2 = 1 point, ECOG score 3 to 4 = 0 points, no extracerebral metastases = 1 point, extracerebral metastases = 0 points. Sum scores were 0 (n = 32), 1 (n = 15), or 2 points (n = 9). Six-month OS rates were 6{\%}, 67{\%}, and 100{\%}, respectively (P < 0.001). Conclusions: A predictive tool including 3 groups with significantly different OS probabilities was designed for patients with cerebral metastases from gynecological cancers. This tool will aid in choosing individual treatments.",
keywords = "Brain metastases, Gynecological cancers, Irradiation, Overall survival, Scoring tool",
author = "Dirk Rades and Stefan Janssen and Amira Bajrovic and Theo Veninga and Dorothea Fischer and Schild, {Steven E.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1097/IGC.0000000000000899",
language = "English (US)",
volume = "27",
pages = "597--602",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Wolters Kluwer Health",
number = "3",

}

TY - JOUR

T1 - A New Scoring Tool to Assess Overall Survival in Patients With Intracerebral Metastases From Gynecological Cancers

AU - Rades, Dirk

AU - Janssen, Stefan

AU - Bajrovic, Amira

AU - Veninga, Theo

AU - Fischer, Dorothea

AU - Schild, Steven E.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Objective: This study aimed to facilitate individualized treatment strategies for intracerebral metastases from gynecological cancers by creating a specific overall survival (OS) score. Methods/Materials Fifty-six patients irradiated for cerebral metastases from gynecological cancers were included. Eleven factors were retrospectively analyzed for OS: age, Eastern Cooperative Oncology Group (ECOG) performance score, cancer type, histology, histologic grading, initial stage, number of lesions, extracerebral metastases, time between cancer diagnosis and brain metastases treatment, recursive partitioning analysis class, and type of treatment. Independent predictors of OS were incorporated in the score (better OS, 1 point; worse OS, 0 points). Results: On Cox proportional hazards analysis, performance score (hazards ratio, 1.98; 95% confidence interval, 1.30-3.23; P = 0.001), no extracerebral metastases (3.34; 1.46-8.96; P = 0.003), and recursive partitioning analysis class 1 (3.27; 1.97-5.65; P < 0.001) were significant. The following points were assigned: ECOG score 1 to 2 = 1 point, ECOG score 3 to 4 = 0 points, no extracerebral metastases = 1 point, extracerebral metastases = 0 points. Sum scores were 0 (n = 32), 1 (n = 15), or 2 points (n = 9). Six-month OS rates were 6%, 67%, and 100%, respectively (P < 0.001). Conclusions: A predictive tool including 3 groups with significantly different OS probabilities was designed for patients with cerebral metastases from gynecological cancers. This tool will aid in choosing individual treatments.

AB - Objective: This study aimed to facilitate individualized treatment strategies for intracerebral metastases from gynecological cancers by creating a specific overall survival (OS) score. Methods/Materials Fifty-six patients irradiated for cerebral metastases from gynecological cancers were included. Eleven factors were retrospectively analyzed for OS: age, Eastern Cooperative Oncology Group (ECOG) performance score, cancer type, histology, histologic grading, initial stage, number of lesions, extracerebral metastases, time between cancer diagnosis and brain metastases treatment, recursive partitioning analysis class, and type of treatment. Independent predictors of OS were incorporated in the score (better OS, 1 point; worse OS, 0 points). Results: On Cox proportional hazards analysis, performance score (hazards ratio, 1.98; 95% confidence interval, 1.30-3.23; P = 0.001), no extracerebral metastases (3.34; 1.46-8.96; P = 0.003), and recursive partitioning analysis class 1 (3.27; 1.97-5.65; P < 0.001) were significant. The following points were assigned: ECOG score 1 to 2 = 1 point, ECOG score 3 to 4 = 0 points, no extracerebral metastases = 1 point, extracerebral metastases = 0 points. Sum scores were 0 (n = 32), 1 (n = 15), or 2 points (n = 9). Six-month OS rates were 6%, 67%, and 100%, respectively (P < 0.001). Conclusions: A predictive tool including 3 groups with significantly different OS probabilities was designed for patients with cerebral metastases from gynecological cancers. This tool will aid in choosing individual treatments.

KW - Brain metastases

KW - Gynecological cancers

KW - Irradiation

KW - Overall survival

KW - Scoring tool

UR - http://www.scopus.com/inward/record.url?scp=85014559917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014559917&partnerID=8YFLogxK

U2 - 10.1097/IGC.0000000000000899

DO - 10.1097/IGC.0000000000000899

M3 - Article

VL - 27

SP - 597

EP - 602

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 3

ER -